Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sembiosys Genetics Inc. SBIYF

"SemBioSys Genetics Inc is engaged in developing high-value proteins and oils in plant seeds using its unique proprietary genetic expression and manufacturing technology platforms. The Company has operations in United States and Canada."


GREY:SBIYF - Post by User

Post by RE38on Feb 06, 2012 10:52am
124 Views
Post# 19494436

Comparing SBS to SCG from last year

Comparing SBS to SCG from last year

SCG has some game changing news with the Iridium card that saw the stock move from 4 cents to 26 in February. A couple weeks later it was back to 11. Then they reiterated the same type of news in May and signed a 5 year deal with Mastercard and the stock shot all the way up to the 70's, mainly riding the wave of INT's huge move.

 

Doesn't that sound similar to SBS? They had the original news in October, the stock price came back down after the spike. Since then EKG increased the market appetite and SBS reiterated the news of their contract with government approval. 

 

Be careful of selling out too soon.

<< Previous
Bullboard Posts
Next >>